We invest the majority of our fund in Europe and the rest in the US. We bridge the continents for our portfolio companies, facilitating partnerships and building international networks to help everyone succeed.
GEOGRAPHY
Europe & United States
SECTORS
Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics
STAGE
From seed to public offerings
INVESTMENT CRITERIA
Potential for a strong exit within 4 to 6 years
FUNDS
Three funds; €301M under management; investments of €10M to €15M
RESPONSIBLE INVESTMENT
Committed to investing responsibly. Read our Responsible Investment Policy here
SYNDICATION
Will lead or co-lead an investment syndicate